Industry · NAICS 325414
Biological Product (Except Diagnostic) Manufacturing
Open notices · Coming up for re-bid · Who wins this work · Typical award sizes
Money by year
Obligations (money committed) in prime awards, from USAspending.gov.
Agencies buying it, FY2025
- Department of Defense $29.23M
- Department of Agriculture $25.55M
- Department of Veterans Affairs $11.62M
- Department of Commerce $676.9K
- Department of Homeland Security $444.1K
- Department of State $265.3K
- Department of the Interior $112.5K
- Smithsonian Institution $52.1K
Offices buying the most, FY2025
- Aspr/Orm-Sns $55.75M
- Mrpbs Minneapolis MN $25.14M
- Dla Troop Support $20.98M
- Army Med Res Acq Activity $5.55M
- National Institutes of Health Niaid $4.23M
- CDC Office of Acquisition Services $3.81M
- National Institutes of Health - CC $3.77M
- 256-Network Contract Office 16 (36C256) $3.09M
Companies winning it, FY2025
- Sanofi $87.22M
- Emergent Biosolutions Inc. $55.75M
- Artemis Technologies Inc $8.05M
- Seqirus Inc $7.64M
- C.H. Boehringer Sohn Ag & Co. KG $7.60M
- American National Red Cross, the $6.40M
- Seqirus USA Inc $6.30M
- Octapharma USA Inc. $5.50M
- Boehringer Ingelheim Animal Health France $5.48M
- Biogenesis Bago S.A. $3.11M
Where the work is, FY2025
- Pennsylvania $38.30M
- (not reported) $33.60M
- (outside the US) $10.13M
- Georgia $7.96M
- New Hampshire $6.51M
- California $5.88M
- Wisconsin $2.52M
- Colorado $2.07M
Contracts ending in the next 12 months
10 contracts, $403.75M with options. The largest:
| Contract | Incumbent | Ends | Value with options |
|---|---|---|---|
| 75A50125C00002 MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE | Sanofi Vaccines US Inc. | 2027-01-31 | $79.84M |
| 36C25626N0272 BLOOD AND BLOOD PRODUCT IN SUPPORT OF MEDVAMC - ORDERING PERIOD 4 | American National Red Cross, the | 2027-01-31 | $3.31M |
| SPE2DP26F4183 8512025830!ANTIDOTE TREATMENT | Meridian Medical Technologies, LLC | 2027-02-26 | $36.47M |
| 36C25526N0172 BLOOD, BLOOD PRODUCTS AND RELATED SERVICES. | American National Red Cross, the | 2027-03-31 | $1.89M |
| 75A50124F61008 THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED | Seqirus Inc | 2027-05-21 | $23.27M |
| 12639526F0654 NAFMDVB ANTIGEN PURCHASE, THIS IS TO BE ORDERED OFF CONTRACT #12639521D0047 | Boehringer Ingelheim Animal Health France | 2027-06-25 | $3.70M |
| 75N98026P00914 THE INDI PROJECT IS A LARGE-SCALE GENOME ENGINEERING EFFORT EMBEDDED WITHIN CARD TO GENERATE DISEASE-RELEVANT IPSC MODELS FOR NEURODEGENERATIVE DISEASE RESEARCH | Jackson Laboratory | 2027-08-31 | $2.99M |
| 75D30126C21514 | Lampire Biological Labs Inc | 2027-09-21 | $1.54M |
| 75D30122C14299 FERRET ANTISERA | University of Georgia Research Foundation, Inc. | 2027-09-28 | $2.25M |
| 75A50424F64001 EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS | Advanced Technology International | 2027-09-29 | $248.50M |
Open notices
- Injectable Egg-Free Influenza Vaccine 2027 · Presolicitation · due 2026-10-08
- Injectable Influenza Vaccine 2027 · Presolicitation · due 2026-10-08
- 2027 Southern Hemisphere Influenza Vaccine · Solicitation · due 2026-10-14
- Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC) · Combined Synopsis/Solicitation · due 2026-11-10 · No Set aside used
From USAspending.gov prime awards and SAM.gov notices. Sources and limits